Concepedia

Ankith Sherapura

AS

Statistics

Publications

7

Citations

138

H-Index

7

Active since

2018

Affiliations

Kuvempu University(Current)

University of Mysore

University of Illinois Chicago

Houston Methodist

Soongsil University

Ankith Sherapura is an author at Kuvempu University specializing in oxadiazole chemistry, oncology pharmacology, and pharmacology.

Publications per year

2018–2023

7

Publications

7

Novel 1,3,4-oxadiazole Targets STAT3 Signaling to Induce Antitumor Effect in Lung Cancer

Vikas H. Malojirao, Swamy Savvemala Girimanchanaika, Muthu K. Shanmugam et al. · Biomedicines · 2020 · 34 citations · Full text

, , +13

Targeting HIF-1α by newly synthesized Indolephenoxyacetamide (IPA) analogs to induce anti-angiogenesis-mediated solid tumor suppression

Fares Hezam Al-Ostoot, Ankith Sherapura, V. Vigneshwaran et al. · Pharmacological Reports · 2021 · 32 citations

, , +12

Synthesis and amelioration of inflammatory paw edema by novel benzophenone appended oxadiazole derivatives by exhibiting cyclooxygenase-2 antagonist activity

Naveen Puttaswamy, Vikas H. Malojiao, Yasser Hussein Eissa Mohammed et al. · Biomedicine & Pharmacotherapy · 2018 · 27 citations

, , +14

Antiproliferative pharmacophore azo-hydrazone analogue BT-1F exerts death signalling pathway targeting STAT3 in solid tumour

Banumathi, Ankith Sherapura, Vikas H. Malojirao et al. · Pharmacological Reports · 2022 · 12 citations

, , +10

Steroidal alkaloid solanidine impedes hypoxia-driven ATM phosphorylation to switch on anti-angiogenesis in lung adenocarcinoma

Ankith Sherapura, B M Siddesh, Vikas H. Malojirao et al. · Phytomedicine · 2023 · 12 citations

, , +13

1–5 of 7